undamentalytics Newsletter

Jonas Daniel S: insider trades

Officer at Conmed Corp. No open-market purchases and 26 sales not made under a pre-set plan, reported from February 8, 2011 to May 2, 2023.

What happened after Jonas Daniel S’s sales?

After their sales, the shares moved −2.2% against the index over 12 months on average (a negative figure means selling was the right call); 46% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Jonas Daniel S: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 26 −1.0% −2.4% 58% 11 −0.68 0.51 No reliable evidence
Sales, 12 months after the report 26 −2.2% +1.0% 46% 11 −0.46 0.66 No reliable evidence
Sales, 12 months after the trade 26 −2.0% +1.4% 46% 11 −0.44 0.67 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Conmed Corp CNMD Special Counsel & Corp Secy026February 8, 2011May 2, 2023

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
May 2, 2023April 28, 2023 CNMD Sale $1,261,043 −21.0%−70.0%−67.9%
March 3, 2023March 2, 2023 CNMD Sale $1,000,150 +22.9%−40.7%−45.1%
March 8, 2022March 4, 2022 CNMD Sale $3,101,196 −16.6%−24.9%−26.4%
March 1, 2022February 25, 2022 CNMD Sale $1,322,465 −15.9%−23.8%−26.6%
September 17, 2021September 15, 2021 CNMD Sale $427,212 −2.0%−20.8%−15.7%
May 4, 2021April 30, 2021 CNMD Sale $2,828,662 −15.2%−5.4%−5.1%
March 3, 2021March 1, 2021 CNMD Sale $863,793 +1.2%+4.9%+6.4%
November 20, 2020November 18, 2020 CNMD Sale $471,680 +11.3%+6.4%+10.0%
November 18, 2020November 17, 2020 CNMD Sale $480,600 +15.3%+8.9%+15.3%
August 3, 2020July 31, 2020 CNMD Sale $359,488 −5.9%+21.6%+30.0%
August 7, 2019August 6, 2019 CNMD Sale $267,919 +10.3%−26.8%−26.7%
April 30, 2019April 26, 2019 CNMD Sale $322,040 +7.4%−8.1%−15.1%
August 6, 2018August 2, 2018 CNMD Sale $318,920 −8.2%+19.8%+12.3%
April 30, 2018April 27, 2018 CNMD Sale $131,160 +6.7%+13.1%+11.5%
May 16, 2017May 15, 2017 CNMD Sale $153,650 −5.9%+20.9%+20.9%
November 9, 2016November 8, 2016 CNMD Sale $62,661 −7.8%−6.0%+0.4%
November 7, 2016November 7, 2016 CNMD Sale $103,222 −4.6%+0.4%+2.4%
June 7, 2013June 7, 2013 CNMD Sale $64,832 +0.8%+20.1%+21.9%
May 30, 2013May 28, 2013 CNMD Sale $576,820 −4.5%+17.0%+16.1%
March 5, 2013March 4, 2013 CNMD Sale $61,780 −1.1%+30.1%+31.3%
December 12, 2012December 11, 2012 CNMD Sale $280,300 +8.3%+19.6%+15.5%
June 18, 2012June 15, 2012 CNMD Sale $81,000 −2.9%−8.5%−5.6%
March 15, 2012March 14, 2012 CNMD Sale $85,582 −3.3%+1.6%−2.3%
March 12, 2012March 8, 2012 CNMD Sale $210,706 −3.8%−1.9%−5.4%
November 10, 2011November 9, 2011 CNMD Sale $81,000 +1.6%−11.8%−11.7%
February 8, 2011February 7, 2011 CNMD Sale $358,930 +6.3%+6.9%+6.5%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Jonas Daniel S traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.